Dermaliq Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Dermaliq Therapeutics's estimated annual revenue is currently $703.5k per year.
- Dermaliq Therapeutics's estimated revenue per employee is $100,500
Employee Data
- Dermaliq Therapeutics has 7 Employees.
- Dermaliq Therapeutics grew their employee count by 17% last year.
Dermaliq Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CSO and co-founder | Reveal Email/Phone |
2 | Clinical Project Manager | Reveal Email/Phone |
Dermaliq Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $34M | 169 | 8% | N/A | N/A |
#2 | $8.4M | 42 | -28% | N/A | N/A |
#3 | $68.7M | 342 | 6% | N/A | N/A |
#4 | $49.4M | 246 | -10% | N/A | N/A |
#5 | $7.8M | 39 | 44% | N/A | N/A |
#6 | $148.3M | 738 | 8% | N/A | N/A |
#7 | $24.7M | 123 | 13% | N/A | N/A |
#8 | $0.8M | 8 | 14% | N/A | N/A |
#9 | $9M | 45 | 7% | N/A | N/A |
#10 | $3.8M | 19 | -50% | N/A | N/A |
What Is Dermaliq Therapeutics?
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The unique and proprietary technology owned by Dermaliq, called hyliQTM, is designed to allow cutaneous drug delivery with unmatched bioavailability. The technology enables the development of superior, highly effective liquid drug products with exceptional cosmetic properties.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$703.5k
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Wilmington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | -12% | N/A |
#2 | $0.5M | 7 | N/A | N/A |
#3 | $0.6M | 7 | -12% | N/A |
#4 | $0.5M | 7 | -22% | N/A |
#5 | $0.9M | 7 | -12% | N/A |
